- Global Pharma News & Resources

BioForward Represents Wisconsin’s Biohealth Industry with Diverse Board of Innovation Leaders

BioForward, Wisconsin’s state association representing over 200 biohealth member companies, announced three additions to this year’s Board of Directors. The board represents many facets of the state’s diverse biohealth industry and focuses on advocating for Wisconsin’s strengths in development of integrated health solutions and academic research.

“Wisconsin’s biohealth industry continues to expand, with over $47.8 Billion in overall economic output and increasing career opportunities, which demonstrates our state’s role as a hub for medical innovation,” said Lisa Johnson, CEO of BioForward. “We’re seeing incredible growth and investment in Wisconsin’s biohealth industry and sought new board members who could advance our key goals, and the continued growth of BioForward members in 2019.”

Newly elected Board Members for the 2019-21 term include:

  • Jon Denissen, Senior Vice President, PPD
  • Carey Case, Site Director API, Alcami
  • Garrett Petersen, Principal/Chief Strategy Officer, Yahara Software

“Our 2018 Economic Impact Report demonstrated the importance and impact of Wisconsin’s biohealth industry and why we advocate on its behalf,” said Nicolas Paris, Chairman of BioForward and CEO of Gilson. “BioForward’s Board of Directors has assembled expertise that will be focused on targeted initiatives that, I believe, will launch our biohealth industry to even greater success.”

More information on the incoming and existing board members can be found on the BioForward website.

View the full Wisconsin’s Biohealth Industry 2018 Economic Impact Report on the BioForward Website

About BioForward Wisconsin

BioForward serves as the independent voice of Wisconsin’s biohealth industry, providing services and resources to support the growth of our industry throughout the U.S. and the world. BioForward is the only Wisconsin organization representing over 200 biohealth member companies including biotech, biopharma, medical device, diagnostics, digital health, as well as health systems, research institutions, and service providers. Our focus in 2019 is advocating on behalf of Wisconsin’s industry strength in integrated health solutions and research. BioForward has implemented several new initiatives with an emphasis on our role as the representatives of this critical industry for the state of Wisconsin.

View source version on

Editor Details

Last Updated: 16-Jan-2019